Neuphoria Therapeutics Inc Capital Reinvestment Ratio
Neuphoria Therapeutics Inc capital reinvestment ratio. Neuphoria Therapeutics Inc (NEUP) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($73.57 Million) in capital expenditures ($3.00). Check Neuphoria Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Neuphoria Therapeutics Inc (2015–2015)
Capital reinvestment ratio of Neuphoria Therapeutics Inc from 2015 to 2015. This chart tracks Neuphoria Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Neuphoria Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Neuphoria Therapeutics Inc Capital Reinvestment Ratio by Year (2015–2015)
Neuphoria Therapeutics Inc capital reinvestment ratio by year from 2015 to 2015. For the full cash flow conversion analysis, see how efficiently does Neuphoria Therapeutics Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.17x | $4.94 Million | $846.26K | — |